Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE

• Published in: PloS one 2009-12, Vol.4 (12), p.e8282
• Main Authors: Nesterovitch, Andrew B, Hogarth, Kyle D, Adarichev, Vyacheslav A, Vinokour, Elena I, Schwartz, David E, Solway, Julian, Danilov, Sergei M
• Format: Article
• Language: English
• Subjects: Air flow; Alleles; Allergies; Amino Acid Substitution - genetics; Amino acids; Anesthesiology; Angiotensin; Angiotensin I; Angiotensins; Animals; Asthma; Base Sequence; Blood; Blood pressure; Blotting, Western; Cardiovascular agents; Cardiovascular diseases; Cardiovascular Disorders; Carriers; Cell Biology; CHO Cells; Cluster Analysis; Codons; Conversion; Cricetinae; Cricetulus; Deoxyribonucleic acid; DNA; DNA Mutational Analysis; Enzymes; Ethnic Groups - genetics; Female; Gene Dosage - genetics; Genetic aspects; Genetics and Genomics/Genetics of Disease; Haplotypes; Haplotypes - genetics; Health risks; Humans; Hypertension; Male; Medicine; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutant Proteins - chemistry; Mutation; Mutation - genetics; Pathology/Molecular Pathology; Pedigree; Peptides; Peptidyl-dipeptidase A; Peptidyl-Dipeptidase A - blood; Peptidyl-Dipeptidase A - chemistry; Peptidyl-Dipeptidase A - genetics; Plasma; Protein Conformation; Recombinant Proteins - genetics; Respiratory diseases; Respiratory tract diseases; Sarcoidosis; Secretion; Stop codon; Transfection
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0008282

Angiotensin-converting enzyme (ACE) metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling. Elevated ACE levels may be associated with an increased risk for different cardiovascular or respiratory diseases, including asthma. Previously, a molecular mechanism underlying a 5-fold familial increase of blood ACE was discovered: Pro1199Leu substitution enhanced the cleavage-secretion process. Carriers of this mutation were Caucasians from Europe (mostly Dutch) or had European roots. We have found a family of African-American descent whose affected members' blood ACE level was increased 13-fold over normal. In affected family members, codon TGG coding for Trp1197 was substituted in one allele by TGA (stop codon). As a result, half of ACE expressed in these individuals had a length of 1196 amino acids and lacked a transmembrane anchor. This ACE mutant is not trafficked to the cell membrane and is directly secreted out of cells; this mechanism apparently accounts for the high serum ACE level seen in affected individuals. A haplotype of the mutant ACE allele was determined based on 12 polymorphisms, which may help to identify other carriers of this mutation. Some but not all carriers of this mutation demonstrated airflow obstruction, and some but not all have hypertension. We have identified a novel Trp1197Stop mutation that results in dramatic elevation of serum ACE. Since blood ACE elevation is often taken as a marker of disease activity (sarcoidosis and Gaucher diseases), it is important for clinicians and medical scientists to be aware of alternative genetic causes of elevated blood ACE that are not apparently linked to disease.